Shares of 10x Genomics (NASDAQ:TXG) slid 5% amid news that a German patent court has ruled against the company as part of a case involving NanoString’s (NSTGQ) CosMx Spatial Molecular Imager products ...
New single cell and spatial products set to deliver higher performance, improve ease of use and enable researchers to measure more biology "The new products we have planned for 2024 will take 10x to ...
First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology "Scientists can now ...
PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ — At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, ...
Since slide-sequencing was developed in 2019 in the academic labs of Evan Macosko, MD, PhD, and Fei Chen, PhD, the technology has been making waves for its ease of use and high resolution. GEN covered ...
In this presentation, Vizgen’s Instrument Product Manager will introduce you to their latest platform, the MERSCOPE® Ultra, for in situ spatial genomics powered by MERFISH technology. MERFISH ...
First fully integrated spatial multiomic assay from 10x Genomics (TXG) brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology PLEASANTON, Calif ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback